Presentation is loading. Please wait.

Presentation is loading. Please wait.

Myeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicity  Sarah J. Stephens, MD, Samantha Thomas, MB,

Published byMargaretMargaret Fleming Modified over 6 years ago

Similar presentations

Presentation on theme: "Myeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicity  Sarah J. Stephens, MD, Samantha Thomas, MB,"— Presentation transcript:

1 Myeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicity  Sarah J. Stephens, MD, Samantha Thomas, MB, David A. Rizzieri, MD, Mitchell E. Horwitz, MD, Nelson J. Chao, MD, Ashley M. Engemann, PharmD, Martha Lassiter, MSN, Chris R. Kelsey, MD  Advances in Radiation Oncology  Volume 1, Issue 4, Pages (October 2016) DOI: /j.adro Copyright © 2016 The Authors on behalf of the American Society for Radiation Oncology Terms and Conditions

2 Figure 1 Kaplan-Meier of leukemia-free survival between patients receiving total body irradiation (TBI) plus chemotherapy compared with chemotherapy alone. Advances in Radiation Oncology 2016 1, DOI: ( /j.adro ) Copyright © 2016 The Authors on behalf of the American Society for Radiation Oncology Terms and Conditions

3 Figure 2 Kaplan-Meier of overall survival between patients receiving total body irradiation (TBI) plus chemotherapy compared with chemotherapy alone. Advances in Radiation Oncology 2016 1, DOI: ( /j.adro ) Copyright © 2016 The Authors on behalf of the American Society for Radiation Oncology Terms and Conditions

4 Figure 3 Cumulative incidence of nonrelapse mortality between patients receiving total body irradiation (TBI) plus chemotherapy compared with chemotherapy alone. Advances in Radiation Oncology 2016 1, DOI: ( /j.adro ) Copyright © 2016 The Authors on behalf of the American Society for Radiation Oncology Terms and Conditions

5 Figure 4 Cumulative incidence of pulmonary toxicity (grades 1-5) between patients receiving total body irradiation (TBI) plus chemotherapy compared with chemotherapy alone. Advances in Radiation Oncology 2016 1, DOI: ( /j.adro ) Copyright © 2016 The Authors on behalf of the American Society for Radiation Oncology Terms and Conditions

Download ppt "Myeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicity  Sarah J. Stephens, MD, Samantha Thomas, MB,"

Similar presentations

Neutron radiation therapy for advanced thyroid cancers Tobias R. Chapman, MD, George E. Laramore, PhD, MD, Stephen R. Bowen, PhD, Peter F. Orio, DO, MS.

Neutron radiation therapy for advanced thyroid cancers Tobias R. Chapman, MD, George E. Laramore, PhD, MD, Stephen R. Bowen, PhD, Peter F. Orio, DO, MS.
Factors Predictive of Relapse of Acute Leukemia in Children after Allogeneic Hematopoietic Cell Transplantation  Nirali N. Shah, Michael J. Borowitz,

Factors Predictive of Relapse of Acute Leukemia in Children after Allogeneic Hematopoietic Cell Transplantation  Nirali N. Shah, Michael J. Borowitz,
Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes  Stuart E. Samuels, MD, PhD, Matthew.

Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes  Stuart E. Samuels, MD, PhD, Matthew.
Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer  Victor E. Chen, BS, Erin.

Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer  Victor E. Chen, BS, Erin.
John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD 

John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD 
Abscopal effect in recurrent colorectal cancer treated with carbon-ion radiation therapy: 2 case reports  Daniel K. Ebner, BS, Tadashi Kamada, MD, PhD,

Abscopal effect in recurrent colorectal cancer treated with carbon-ion radiation therapy: 2 case reports  Daniel K. Ebner, BS, Tadashi Kamada, MD, PhD,
Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisions  Chelsea.

Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisions  Chelsea.
Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy  Fady F. Youssef, MS, Parag.

Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy  Fady F. Youssef, MS, Parag.
Jarrod D. Predina, BA, Matthew M. Puc, MD, Meredith R

Jarrod D. Predina, BA, Matthew M. Puc, MD, Meredith R
Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial  Susanne M.

Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial  Susanne M.
A phase 2 trial of salvage radiation and concurrent weekly docetaxel after a rising prostate-specific antigen level after radical prostatectomy  William.

A phase 2 trial of salvage radiation and concurrent weekly docetaxel after a rising prostate-specific antigen level after radical prostatectomy  William.
The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis  K.

The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis  K.
Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and.

Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and.
Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease  Joseph P. Archie, PhD, MD  Journal of Vascular.
Tijana Skrepnik, MD, Silvija Gottesman, MD, Baldassarre Stea, MD, PhD 

Tijana Skrepnik, MD, Silvija Gottesman, MD, Baldassarre Stea, MD, PhD 
Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery.

Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery.
Incidence and Causes of Hospital Readmission in Pediatric Patients after Hematopoietic Cell Transplantation  David Stephen Shulman, Wendy B. London, Dongjing.

Incidence and Causes of Hospital Readmission in Pediatric Patients after Hematopoietic Cell Transplantation  David Stephen Shulman, Wendy B. London, Dongjing.
Pleurectomy/Decortication, Hyperthermic Pleural Lavage with Povidone-Iodine Followed by Adjuvant Chemotherapy in Patients with Malignant Pleural Mesothelioma 

Pleurectomy/Decortication, Hyperthermic Pleural Lavage with Povidone-Iodine Followed by Adjuvant Chemotherapy in Patients with Malignant Pleural Mesothelioma 
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 

Similar presentations

Ads by Google